Class I recall: Victory Medical Center Pharmacy: Glutathione (MDV), 200 mg/mL, 30 mL vial, each mL contains Glutathione 200 mg, A
FDA has classified as Class I a recall of Victory Medical Center Pharmacy's Glutathione (MDV) 200 mg/mL, 30 mL multi-dose vial injection, which also contains Ascorbic Acid, Benzyl Alcohol, and sodium hydroxide for pH adjustment. The recall was initiated after out-of-specification results were obtained for bacterial endotoxin, indicating microbial contamination of the sterile product. FDA designates Class I recalls as involving situations where use of the product could cause serious adverse health consequences or death.
Most relevant for: Patients who have received injections of contaminated glutathione from Victory Medical Center Pharmacy and are at risk for serious adverse health consequences from microbial contamination
Read the original at FDA Drug Enforcement ReportsSummary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.
Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.
Specialties
More internal medicine updates
- Long-acting injectable noninferior to oral HIV therapy in adherence trialOct 15, 2026
- Ponatinib-Blinatumomab Beats Imatinib-Chemotherapy in Ph-Positive ALL TrialOct 15, 2026
- Isoflurane sedation does not lower mortality in hypoxemic respiratory failureOct 14, 2026
- Trial finds higher mortality with intermittent vs continuous renal-replacement therapyOct 14, 2026
- No Overall Rise in Birth Defects With Early Benzodiazepine UseOct 13, 2026